Action in Diabetes and Vascular Disease Preterax and Diamicron MR Controlled Evaluation Post Trial Observational Study.
Phase of Trial: Phase IV
Latest Information Update: 08 Jun 2016
At a glance
- Drugs Gliclazide (Primary) ; Perindopril/indapamide (Primary) ; Antihyperglycaemics
- Indications Cardiovascular disorders; Diabetic angiopathies; Diabetic complications; Diabetic retinopathy; Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms ADVANCE-ON
- 09 Apr 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 18 Jan 2014 United Kingdom Clinical Research Network reports planned end date as 1 April 2014.
- 21 Jun 2012 United Kingdom Clinical Research Network reports accrual to date changed from 8% to 9%.